(+)-epicatechin-3-O-gallate multiple interactions ISO RGD:732520 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [Hydrogen Peroxide affects the expression of BMAL1 mRNA] more ... CTD PMID:29061316 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BMAL1 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732520 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [Hydrogen Peroxide affects the expression of BMAL1 mRNA] more ... CTD PMID:22079256 , PMID:29061316 (1->4)-beta-D-glucan multiple interactions ISO RGD:62295 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARNTL mRNA CTD PMID:36331819 1,2-dichloroethane increases expression ISO RGD:62295 6480464 ethylene dichloride results in increased expression of BMAL1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:62295 6480464 1, 2-Dimethylhydrazine results in increased expression of BMAL1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:62295 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of BMAL1 mRNA] CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:62295 6480464 [Polyphenols co-treated with Estradiol] results in decreased expression of BMAL1 mRNA CTD PMID:30077407 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:62295 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:62295 6480464 2 more ... CTD PMID:30294300 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:62295 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BMAL1 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62295 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:21182907 , PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62295 6480464 Tetrachlorodibenzodioxin results in decreased expression of BMAL1 mRNA CTD PMID:18295293 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62295 6480464 Tetrachlorodibenzodioxin results in increased expression of BMAL1 mRNA CTD PMID:18487412 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62295 6480464 Tetrachlorodibenzodioxin affects the expression of BMAL1 mRNA, Tetrachlorodibenzodioxin affects the expression of BMAL1 protein CTD PMID:21182907 more ... 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:62295 6480464 Glucosamine results in decreased expression of BMAL1 mRNA, Glucosamine results in decreased expression of BMAL1 protein CTD PMID:24442997 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of BMAL1 mRNA CTD PMID:28300664 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:62295 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of BMAL1 mRNA CTD PMID:26251327 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of BMAL1 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732520 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BMAL1 mRNA CTD PMID:28628672 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide increases acetylation ISO RGD:62295 6480464 6-chloro-2 more ... CTD PMID:31768571 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of BMAL1 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:62295 6480464 Acrylamide results in decreased expression of BMAL1 mRNA CTD PMID:30807115 aflatoxin B1 increases methylation ISO RGD:732520 6480464 Aflatoxin B1 results in increased methylation of BMAL1 gene CTD PMID:27153756 aldehydo-D-glucosamine decreases expression ISO RGD:62295 6480464 Glucosamine results in decreased expression of BMAL1 mRNA, Glucosamine results in decreased expression of BMAL1 protein CTD PMID:24442997 all-trans-retinoic acid decreases expression ISO RGD:732520 6480464 Tretinoin results in decreased expression of BMAL1 mRNA CTD PMID:23724009 all-trans-retinoic acid multiple interactions ISO RGD:62295 6480464 RARA protein inhibits the reaction [Tretinoin results in increased activity of [CLOCK protein binds to BMAL1 protein]], Tretinoin results in increased activity of [CLOCK protein binds to BMAL1 protein] CTD PMID:17069763 all-trans-retinoic acid increases expression ISO RGD:62295 6480464 Tretinoin results in increased expression of BMAL1 mRNA CTD PMID:9704006 amino acid increases abundance ISO RGD:62295 6480464 BMAL1 gene mutant form results in increased abundance of Amino Acids CTD PMID:27056296 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BMAL1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:732520 6480464 Antirheumatic Agents results in decreased expression of BMAL1 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:732520 6480464 aristolochic acid I results in decreased expression of BMAL1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:62295 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of BMAL1 mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:732520 6480464 Arsenic affects the methylation of BMAL1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:732520 6480464 Arsenic affects the methylation of BMAL1 gene CTD PMID:25304211 atrazine decreases expression ISO RGD:732520 6480464 Atrazine results in decreased expression of BMAL1 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:732520 6480464 Benzo(a)pyrene results in decreased expression of BMAL1 mRNA CTD PMID:21632981 more ... benzo[a]pyrene decreases expression ISO RGD:62295 6480464 Benzo(a)pyrene results in decreased expression of BMAL1 mRNA CTD PMID:19770486 benzo[a]pyrene multiple interactions ISO RGD:62295 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMAL1 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:62295 6480464 Benzo(a)pyrene results in increased expression of BMAL1 mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:732520 6480464 Benzo(a)pyrene affects the methylation of BMAL1 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:732520 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene multiple interactions ISO RGD:62295 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMAL1 mRNA CTD PMID:27858113 benzo[b]fluoranthene decreases expression ISO RGD:62295 6480464 benzo(b)fluoranthene results in decreased expression of BMAL1 mRNA CTD PMID:26377693 Benzo[k]fluoranthene decreases expression ISO RGD:62295 6480464 benzo(k)fluoranthene results in decreased expression of BMAL1 mRNA CTD PMID:26377693 beta-D-glucosamine decreases expression ISO RGD:62295 6480464 Glucosamine results in decreased expression of BMAL1 mRNA, Glucosamine results in decreased expression of BMAL1 protein CTD PMID:24442997 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of BMAL1 mRNA CTD PMID:18164116 beta-naphthoflavone multiple interactions ISO RGD:62295 6480464 beta-Naphthoflavone inhibits the reaction [CLOCK protein binds to BMAL1 protein] more ... CTD PMID:20106950 , PMID:21849270 beta-naphthoflavone increases expression ISO RGD:732520 6480464 beta-Naphthoflavone results in increased expression of BMAL1 mRNA CTD PMID:32151702 bezafibrate multiple interactions ISO RGD:62295 6480464 [CLOCK protein binds to BMAL1 protein] promotes the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA] CTD PMID:20400680 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of BMAL1 mRNA CTD PMID:28871463 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:62295 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:62295 6480464 Diethylhexyl Phthalate results in decreased expression of BMAL1 mRNA CTD PMID:19245819 bis(2-ethylhexyl) phthalate increases expression ISO RGD:732520 6480464 Diethylhexyl Phthalate results in increased expression of BMAL1 mRNA CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BMAL1 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:62295 6480464 bisphenol A results in increased methylation of BMAL1 promoter CTD PMID:27312807 bisphenol A decreases expression ISO RGD:62295 6480464 bisphenol A results in decreased expression of BMAL1 mRNA CTD PMID:25594700 bisphenol A multiple interactions ISO RGD:732520 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BMAL1 mRNA CTD PMID:28628672 bisphenol A multiple interactions ISO RGD:62295 6480464 [ATF3 protein affects the reaction [bisphenol A results in increased expression of NPY mRNA]] which affects the expression of BMAL1 mRNA more ... CTD PMID:28433925 more ... bisphenol A increases expression ISO RGD:62295 6480464 bisphenol A results in increased expression of BMAL1 mRNA, bisphenol A results in increased expression of BMAL1 protein CTD PMID:30500912 , PMID:33297044 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of BMAL1 mRNA CTD PMID:32479839 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of BMAL1 mRNA CTD PMID:19167457 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of BMAL1, Cadmium Chloride affects the expression of BMAL1 mRNA CTD PMID:21442002 , PMID:23085516 cadmium dichloride multiple interactions EXP 6480464 Melatonin inhibits the reaction [Cadmium Chloride affects the expression of BMAL1] CTD PMID:23085516 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of BMAL1 mRNA CTD PMID:20107868 calcium silicate increases expression ISO RGD:62295 6480464 calcium silicate results in increased expression of BMAL1 mRNA CTD PMID:29279043 cannabidiol increases expression ISO RGD:62295 6480464 Cannabidiol results in increased expression of BMAL1 mRNA CTD PMID:30307084 carbon nanotube decreases expression ISO RGD:62295 6480464 Nanotubes, Carbon analog results in decreased expression of BMAL1 mRNA CTD PMID:25554681 , PMID:25620056 carbon nanotube increases expression ISO RGD:62295 6480464 Nanotubes, Carbon results in increased expression of BMAL1 mRNA CTD PMID:25554681 , PMID:25620056 carmustine decreases expression EXP 6480464 Carmustine results in decreased expression of BMAL1 mRNA CTD PMID:16005536 carnosine increases abundance ISO RGD:62295 6480464 BMAL1 gene mutant form results in increased abundance of Carnosine CTD PMID:27056296 casticin decreases expression ISO RGD:62295 6480464 casticin results in decreased expression of BMAL1 mRNA CTD PMID:28444820 CGP 52608 multiple interactions ISO RGD:732520 6480464 CGP 52608 promotes the reaction [RORA protein binds to BMAL1 gene] CTD PMID:28238834 CGS-21680 increases expression ISO RGD:732520 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in increased expression of BMAL1 mRNA CTD PMID:22923002 CGS-21680 multiple interactions ISO RGD:732520 6480464 [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine co-treated with TNF protein] results in increased expression of BMAL1 mRNA CTD PMID:22923002 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of BMAL1 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:62295 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of BMAL1 mRNA CTD PMID:29127188 chrysene multiple interactions ISO RGD:62295 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMAL1 mRNA CTD PMID:27858113 chrysene decreases expression ISO RGD:62295 6480464 chrysene results in decreased expression of BMAL1 mRNA CTD PMID:26377693 cisplatin decreases expression ISO RGD:62295 6480464 Cisplatin results in decreased expression of BMAL1 mRNA CTD PMID:25270620 clofibrate decreases expression ISO RGD:62295 6480464 Clofibrate results in decreased expression of BMAL1 mRNA CTD PMID:17585979 cocaine decreases expression ISO RGD:62295 6480464 Cocaine results in decreased expression of BMAL1 mRNA CTD PMID:15994025 colforsin daropate hydrochloride increases expression ISO RGD:62295 6480464 Colforsin results in increased expression of BMAL1 mRNA CTD PMID:30524225 copper atom multiple interactions ISO RGD:732520 6480464 [NSC 689534 binds to Copper] which results in increased expression of BMAL1 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:732520 6480464 [NSC 689534 binds to Copper] which results in increased expression of BMAL1 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:732520 6480464 Copper Sulfate results in decreased expression of BMAL1 mRNA CTD PMID:19549813 cortisol decreases expression ISO RGD:732520 6480464 Hydrocortisone results in decreased expression of BMAL1 mRNA CTD PMID:21980503 creatinine increases abundance ISO RGD:62295 6480464 BMAL1 gene mutant form results in increased abundance of Creatinine CTD PMID:27056296 cyclosporin A decreases expression ISO RGD:732520 6480464 Cyclosporine results in decreased expression of BMAL1 mRNA CTD PMID:25562108 dexamethasone affects expression ISO RGD:732520 6480464 Dexamethasone affects the expression of BMAL1 mRNA CTD PMID:23251369 dexamethasone affects expression ISO RGD:62295 6480464 Dexamethasone affects the expression of BMAL1 mRNA CTD PMID:29040059 dexamethasone multiple interactions ISO RGD:732520 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BMAL1 mRNA CTD PMID:28628672 dibenz[a,h]anthracene decreases expression ISO RGD:62295 6480464 1 more ... CTD PMID:26377693 dichloromethane decreases expression ISO RGD:62295 6480464 Methylene Chloride results in decreased expression of BMAL1 mRNA CTD PMID:28392392 dimethylarsinic acid multiple interactions ISO RGD:62295 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BMAL1 mRNA CTD PMID:34876320 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of BMAL1 mRNA CTD PMID:33729688 dorsomorphin multiple interactions ISO RGD:732520 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMAL1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732520 6480464 Doxorubicin results in decreased expression of BMAL1 mRNA CTD PMID:29803840 doxorubicin decreases acetylation ISO RGD:62295 6480464 Doxorubicin results in decreased acetylation of BMAL1 protein CTD PMID:31768571 doxorubicin multiple interactions ISO RGD:62295 6480464 Doxorubicin affects the reaction [SIRT1 protein affects the acetylation of BMAL1 protein], Doxorubicin results in decreased expression of and results in increased acetylation of BMAL1 protein CTD PMID:31768571 entinostat increases expression ISO RGD:732520 6480464 entinostat results in increased expression of BMAL1 mRNA CTD PMID:27188386 epoxiconazole affects expression ISO RGD:62295 6480464 epoxiconazole affects the expression of BMAL1 mRNA CTD PMID:35436446 Erionite increases expression ISO RGD:62295 6480464 erionite results in increased expression of BMAL1 mRNA CTD PMID:29279043 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of BMAL1 mRNA CTD PMID:18035473 fluoxetine increases expression ISO RGD:62295 6480464 Fluoxetine results in increased expression of BMAL1 mRNA CTD PMID:15994025 folic acid multiple interactions ISO RGD:62295 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of BMAL1 mRNA more ... CTD PMID:22206623 , PMID:29127188 furan increases expression ISO RGD:62295 6480464 furan results in increased expression of BMAL1 mRNA CTD PMID:24183702 furosemide decreases secretion ISO RGD:62295 6480464 BMAL1 gene mutant form results in decreased secretion of Furosemide CTD PMID:27056296 gadolinium atom multiple interactions ISO RGD:732520 6480464 [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of BMAL1 protein CTD PMID:34878122 gadolinium trichloride multiple interactions ISO RGD:732520 6480464 [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of BMAL1 protein CTD PMID:34878122 gallic acid multiple interactions ISO RGD:732520 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [Hydrogen Peroxide affects the expression of BMAL1 mRNA] more ... CTD PMID:29061316 gallic acid increases expression ISO RGD:732520 6480464 Gallic Acid results in increased expression of BMAL1 mRNA CTD PMID:34408198 gallocatechin multiple interactions ISO RGD:732520 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [Hydrogen Peroxide affects the expression of BMAL1 mRNA] more ... CTD PMID:29061316 geraniol increases expression ISO RGD:732520 6480464 geraniol results in increased expression of BMAL1 mRNA CTD PMID:27683099 gold atom multiple interactions ISO RGD:62295 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of BMAL1 mRNA CTD PMID:19695318 gold(0) multiple interactions ISO RGD:62295 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of BMAL1 mRNA CTD PMID:19695318 graphene oxide decreases expression ISO RGD:62295 6480464 graphene oxide analog results in decreased expression of BMAL1 mRNA, graphene oxide results in decreased expression of BMAL1 mRNA CTD PMID:33227293 hexadecanoic acid decreases expression ISO RGD:62295 6480464 Palmitic Acid results in decreased expression of BMAL1 mRNA, Palmitic Acid results in decreased expression of BMAL1 protein CTD PMID:24442997 hydrogen peroxide affects expression ISO RGD:732520 6480464 Hydrogen Peroxide affects the expression of BMAL1 mRNA, Hydrogen Peroxide affects the expression of BMAL1 protein CTD PMID:29061316 , PMID:30316844 hydrogen peroxide multiple interactions ISO RGD:62295 6480464 BMAL1 protein affects the reaction [Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX2 protein]] more ... CTD PMID:30316844 hydrogen peroxide multiple interactions ISO RGD:732520 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [Hydrogen Peroxide affects the expression of BMAL1 mRNA] more ... CTD PMID:29061316 , PMID:30316844 Hypaconitine multiple interactions ISO RGD:62295 6480464 [BMAL1 protein affects the expression of CYP3A11 mRNA] which affects the susceptibility to hypaconitine, [BMAL1 protein affects the expression of CYP3A11 protein] which affects the metabolism of hypaconitine CTD PMID:31150629 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:62295 6480464 indeno(1 more ... CTD PMID:26377693 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMAL1 mRNA CTD PMID:22129741 indometacin multiple interactions ISO RGD:732520 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BMAL1 mRNA CTD PMID:28628672 isoprenaline increases expression ISO RGD:62295 6480464 Isoproterenol results in increased expression of BMAL1 mRNA CTD PMID:20003209 L-methionine multiple interactions ISO RGD:62295 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of BMAL1 mRNA CTD PMID:29127188 lead(0) affects expression ISO RGD:732520 6480464 Lead affects the expression of BMAL1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:732520 6480464 Lead affects the expression of BMAL1 mRNA CTD PMID:28903495 lysophosphatidylcholine affects abundance ISO RGD:62295 6480464 BMAL1 gene mutant form affects the abundance of Lysophosphatidylcholines CTD PMID:27056296 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of BMAL1 mRNA CTD PMID:28511934 melatonin multiple interactions EXP 6480464 Melatonin affects the reaction [Rotenone affects the expression of BMAL1 mRNA], Melatonin inhibits the reaction [Cadmium Chloride affects the expression of BMAL1] CTD PMID:23085516 , PMID:25430725 metformin decreases expression EXP 6480464 Metformin results in decreased expression of BMAL1 mRNA CTD PMID:31324951 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of BMAL1 mRNA, Methamphetamine results in increased expression of BMAL1 protein CTD PMID:35863504 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of BMAL1 mRNA CTD PMID:16005536 methotrexate affects expression ISO RGD:62295 6480464 Methotrexate affects the expression of BMAL1 mRNA CTD PMID:18502557 methotrexate decreases expression ISO RGD:732520 6480464 Methotrexate results in decreased expression of BMAL1 mRNA CTD PMID:24449571 methylarsonic acid multiple interactions ISO RGD:62295 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BMAL1 mRNA CTD PMID:34876320 milrinone decreases expression EXP 6480464 Milrinone results in decreased expression of BMAL1 mRNA CTD PMID:22936366 mitomycin C decreases expression ISO RGD:62295 6480464 Mitomycin results in decreased expression of BMAL1 mRNA CTD PMID:25270620 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMAL1 mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of BMAL1 mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMAL1 mRNA CTD PMID:18164116 , PMID:22129741 NAD zwitterion decreases oxidation ISO RGD:62295 6480464 BMAL1 gene mutant form results in decreased oxidation of NAD CTD PMID:27056296 NAD(+) decreases oxidation ISO RGD:62295 6480464 BMAL1 gene mutant form results in decreased oxidation of NAD CTD PMID:27056296 paracetamol affects expression ISO RGD:62295 6480464 Acetaminophen affects the expression of BMAL1 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of BMAL1 mRNA CTD PMID:32680482 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of BMAL1 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:62295 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARNTL mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ARNTL mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of BMAL1 mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:62295 6480464 Phenobarbital affects the expression of BMAL1 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:62295 6480464 Phenobarbital results in increased expression of BMAL1 mRNA CTD PMID:19270015 phenobarbital decreases expression ISO RGD:62295 6480464 Phenobarbital results in decreased expression of BMAL1 mRNA CTD PMID:19270015 phosphatidylcholine increases abundance ISO RGD:62295 6480464 BMAL1 gene mutant form results in increased abundance of Phosphatidylcholines CTD PMID:27056296 pirinixic acid increases expression ISO RGD:62295 6480464 pirinixic acid results in increased expression of BMAL1 mRNA CTD PMID:18445702 , PMID:23811191 pirinixic acid decreases expression ISO RGD:62295 6480464 pirinixic acid results in decreased expression of BMAL1 mRNA CTD PMID:17426115 potassium chromate decreases expression ISO RGD:732520 6480464 potassium chromate(VI) results in decreased expression of BMAL1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:732520 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BMAL1 mRNA CTD PMID:22079256 prednisolone increases expression ISO RGD:732520 6480464 Prednisolone results in increased expression of BMAL1 mRNA CTD PMID:16269518 prednisolone increases expression ISO RGD:62295 6480464 Prednisolone results in increased expression of BMAL1 mRNA CTD PMID:16269518 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:62295 6480464 Pregnenolone Carbonitrile results in decreased expression of BMAL1 mRNA CTD PMID:27413110 progesterone increases expression ISO RGD:732520 6480464 Progesterone results in increased expression of BMAL1 mRNA CTD PMID:20096720 quercetin increases expression ISO RGD:732520 6480464 Quercetin results in increased expression of BMAL1 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:62295 6480464 Resveratrol inhibits the reaction [Sodium Fluoride results in decreased expression of BMAL1 protein] CTD PMID:36063856 rotenone multiple interactions EXP 6480464 [lipopolysaccharide more ... CTD PMID:25430725 , PMID:30328585 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of BMAL1 mRNA CTD PMID:28374803 rotenone affects expression EXP 6480464 Rotenone affects the expression of BMAL1 mRNA CTD PMID:25430725 SB 431542 multiple interactions ISO RGD:732520 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMAL1 mRNA CTD PMID:27188386 Se-methyl-L-selenocysteine decreases expression EXP 6480464 selenomethylselenocysteine results in decreased expression of BMAL1 mRNA CTD PMID:19122877 Se-methylselenocysteine decreases expression EXP 6480464 selenomethylselenocysteine results in decreased expression of BMAL1 mRNA CTD PMID:19122877 sevoflurane affects expression EXP 6480464 Sevoflurane affects the expression of BMAL1 mRNA CTD PMID:15967596 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of BMAL1 mRNA CTD PMID:32721576 silver atom decreases expression ISO RGD:62295 6480464 Silver results in decreased expression of BMAL1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:62295 6480464 Silver results in decreased expression of BMAL1 mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:62295 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BMAL1 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:732520 6480464 sodium arsenite results in decreased expression of BMAL1 mRNA CTD PMID:34032870 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of BMAL1 mRNA CTD PMID:35314868 sodium arsenite increases expression ISO RGD:62295 6480464 sodium arsenite results in increased expression of BMAL1 mRNA CTD PMID:18812580 sodium arsenite multiple interactions ISO RGD:62295 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BMAL1 mRNA CTD PMID:34876320 sodium fluoride multiple interactions ISO RGD:62295 6480464 Resveratrol inhibits the reaction [Sodium Fluoride results in decreased expression of BMAL1 protein] CTD PMID:36063856 sodium fluoride decreases expression ISO RGD:62295 6480464 Sodium Fluoride results in decreased expression of BMAL1 mRNA, Sodium Fluoride results in decreased expression of BMAL1 protein CTD PMID:36063856 streptozocin multiple interactions ISO RGD:62295 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of BMAL1 mRNA CTD PMID:29127188 styrene decreases expression ISO RGD:62295 6480464 Styrene results in decreased expression of BMAL1 mRNA CTD PMID:28951217 sunitinib increases expression ISO RGD:732520 6480464 Sunitinib results in increased expression of BMAL1 mRNA CTD PMID:31533062 taurine increases abundance ISO RGD:62295 6480464 BMAL1 gene mutant form results in increased abundance of Taurine CTD PMID:27056296 testosterone increases expression ISO RGD:62295 6480464 Testosterone results in increased expression of BMAL1 mRNA CTD PMID:22539767 testosterone increases expression ISO RGD:732520 6480464 Testosterone results in increased expression of BMAL1 mRNA CTD PMID:33359661 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of BMAL1 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:62295 6480464 Carbon Tetrachloride results in increased expression of BMAL1 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BMAL1 mRNA] CTD PMID:31150632 tetraphene multiple interactions ISO RGD:62295 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMAL1 mRNA CTD PMID:27858113 tetraphene decreases expression ISO RGD:62295 6480464 benz(a)anthracene results in decreased expression of BMAL1 mRNA CTD PMID:26377693 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BMAL1 mRNA CTD PMID:34492290 tioguanine decreases expression EXP 6480464 Thioguanine results in decreased expression of BMAL1 mRNA CTD PMID:16005536 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of BMAL1 mRNA CTD PMID:30012374 titanium dioxide increases expression ISO RGD:62295 6480464 titanium dioxide results in increased expression of BMAL1 mRNA CTD PMID:23557971 tremolite asbestos increases expression ISO RGD:62295 6480464 tremolite results in increased expression of BMAL1 mRNA CTD PMID:29279043 tributylstannane decreases expression ISO RGD:62295 6480464 tributyltin results in decreased expression of BMAL1 mRNA CTD PMID:31939706 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of BMAL1 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:62295 6480464 triptonide results in increased expression of BMAL1 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:732520 6480464 tris(2-butoxyethyl) phosphate affects the expression of BMAL1 mRNA CTD PMID:29024780 urea increases abundance ISO RGD:62295 6480464 BMAL1 gene mutant form results in increased abundance of Urea CTD PMID:27056296 urethane increases expression ISO RGD:732520 6480464 Urethane results in increased expression of BMAL1 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:732520 6480464 Valproic Acid results in decreased methylation of BMAL1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:62295 6480464 Valproic Acid results in increased expression of BMAL1 mRNA CTD PMID:29229235 valproic acid affects expression ISO RGD:62295 6480464 Valproic Acid affects the expression of BMAL1 mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:732520 6480464 Valproic Acid results in increased expression of BMAL1 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:732520 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMAL1 mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:732520 6480464 Valproic Acid affects the expression of BMAL1 mRNA CTD PMID:25979313 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of BMAL1 gene CTD PMID:31682807 vorinostat increases expression ISO RGD:62295 6480464 Vorinostat results in increased expression of BMAL1 mRNA CTD PMID:29229235 zinc atom multiple interactions ISO RGD:732520 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of BMAL1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:732520 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of BMAL1 mRNA CTD PMID:18593933 zoledronic acid increases expression ISO RGD:732520 6480464 Zoledronic Acid results in increased expression of BMAL1 mRNA CTD PMID:20977926